NGS – Genomic Testing Cooperative

Genomic Testing Cooperative (GTC) to Share 12 Ground-breaking Abstracts at the 2025 American Society of Hematology (ASH) Annual Meeting in Orlando

December 2, 2025

Lake Forest, CA — December 2, 2025 — Genomic Testing Cooperative (GTC), a leading provider of integrated DNA and RNA next-generation sequencing (NGS) solutions for hematologic tumors and liquid biopsy applications, today announced that its work and data will be presented in 12 abstracts at the ASH 2025 Annual Meeting

Genomic Testing Cooperative Receives UKCA Mark for its Portfolio of Hematology, Solid Tumors and Liquid Biopsy Profiles covering DNA and RNA

April 8, 2025

Lake Forest, CA – April 8, 2025 – Genomic Testing Cooperative (GTC) today announced it received UKCA marks for its Hematology Profile Plus, Solid Tumor Plus as well as its Liquid Trace Hematology and Liquid Trace Solid Tumor for both solid tumors and hematology that provide comprehensive clinically actionable insights

Updates on the Biological Heterogeneity of Mantle Cell Lymphoma

February 27, 2025

Andrew Ip 1,2,*,† , Maciej Kabat 3,† , Lindsay Fogel 1,4 , Hassan Alkhatatneh 5 , Jason Voss 2, Amolika Gupta 4,6,Alexandra Della Pia 2 , Lori A. Leslie 1,2 , Tatyana Feldman 1,2, Maher Albitar 7 and Andre H. Goy 1,2 1 Department of Oncology, Hackensack Meridian School of

ASH22 Posters

December 13, 2022

GTC presented abstracts at ASH 2022 GTC’s posters from 2022 Convention of American Society of Hematology are now available to be downloaded. Please reach out with any questions. Download Poster Download Poster Want to explore more of our scientific content? Discover additional articles, videos, publications Search Search

Genomic Testing Cooperative Aims to Expand Clinical, Commercial NGS Access With Co-Op Model

August 26, 2020

Jul 23, 2020 | John Gilmore NEW YORK – As part of plans to establish a country-wide network of labs for minimizing the cost of sequencing, Genomic Testing Cooperative (GTC) has launched a joint venture with Hackensack Meridian Health (HMH) that will analyze clinical samples from patients with a variety

Acute Myeloid Leukemia | ASH Annual Meeting Abstract

November 26, 2018

Session: 613. Acute Myeloid Leukemia: Clinical Studies: Poster I Molecular Epidemiologic Associations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) within the United States Dr. Albitar’s molecular work is presented at the ASH meeting in oral and poster presentations Saturday, December 1, 2018, 6:15 PM-8:15 PM | Hall GH (San

Press Release – Genomic Testing Cooperative

November 1, 2018

Genomic Testing Cooperative, a Limited Cooperative Association, Launches a New Platform for Affordable Genomic Cancer Profiling Irvine, California-November 1, 2018 – Genomic Testing Cooperative (GTC), a Limited Cooperative Association, announced today that it will offer multiple laboratory-developed genomic profiling tests for hematologic and solid tumors using next-generation sequencing (NGS) technology. The

Tag: NGS